News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Ginger Shupe, MD

Ginger Shupe, MD

Dr Shupe is the medical director of outpatient psychiatry at Larkin Community Hospital.

Articles by Ginger Shupe, MD

Ginger Shupe, MD

Novel Therapeutic Targets for Major Depressive Disorder: In Conversation With Ginger Shupe, MD

ByGinger Shupe, MD

November 22nd 2025

What novel treatments can be game changers for major depressive disorder?

Latest Updated Articles

Trending on Psychiatric Times

Improving Outcomes in Schizophrenia With Long-Acting Injectables: Insights from the Southern Florida Psychiatry Conference

Prescription Digital Therapeutics: Transforming Health Care Delivery

Addressing Treatment-Resistant Depression: Opportunities and Challenges

Tolerance to Stimulant Medications in the Treatment of Children With ADHD

The Positive Impact of Prescription Digital Therapeutics: Insights From Patricia Ares-Romero, MD

© 2025 MJH Life Sciences^®

All rights reserved.